EM-800, a Novel Antiestrogen, Acts as a Pure Antagonist of the Transcriptional Functions of Estrogen Receptors α and β*-Reference-Cited by-同舟云学术

EM-800, a Novel Antiestrogen, Acts as a Pure Antagonist of the Transcriptional Functions of Estrogen Receptors α and β*

Author:

Tremblay André¹,Tremblay Gilles B.¹,Labrie Claude²,Labrie Fernand²,Giguère Vincent¹³

Affiliation:

1. Molecular Oncology Group, Royal Victoria Hospital (A.T., G.B.T., V.G.), Montreal, Québec, Canada H3A 1A1

2. Laboratory of Molecular Endocrinology, CHUL Research Center (C.L., F.L.), Québec City, Québec, Canada G1V 4G2

3. Departments of Biochemistry, Medicine, and Oncology, McGill University (V.G.), Montreal, Québec, Canada H3A 1A1

Publisher

The Endocrine Society

Subject

Endocrinology

Link

Reference43 articles.

1. Development of antiestrogens and thier use in breast cancer: Eighth Cain Memorial Award Lecture.;Lerner;Cancer Res,1990

5. Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β.;Tremblay;Mol Endocrinol,1997

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Estrogen receptor ligands: a patent review update;Expert Opinion on Therapeutic Patents;2013-05-29

5. Female Sex Hormones, Contraceptives, And Fertility Drugs;Burger's Medicinal Chemistry and Drug Discovery;2010-09-15